On Tuesday, in the course of current trade, Shares of Darling Ingredients Inc (NYSE:DAR), climbed 0.06%, and is now trading at $ 15.50.
Darling Ingredients declared that Darling Global Finance B.V., a wholly-owned indirect partner of the Company incorporated under the laws of The Netherlands, has launched an offering of EUR515 million in aggregate principal amount of its unsecured senior notes. The Notes will be guaranteed by the Company and by all of the Company’s restricted auxiliaries, other than any foreign partner, the Issuer or any receivables entity, that guarantee the Company’s senior secured credit facilities under its Second Amended and Restated Credit Agreement dated January 6, 2014 The offering is subject to market and other conditions.
Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients worldwide. It operates in three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients. The company offers a range of ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy, and fertilizer industries.
During an Afternoon trade, Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), dipped - 5.03%, and is now trading at $ 0.2830.
AEterna Zentaris, declared that it has received written scientific advice from the European Medicines Agency regarding the further development plan, counting the study design, for the new confirmatory Phase 3 clinical study of Macrilen™ (macimorelin) for use in evaluating adult growth hormone deficiency (“AGHD”), following a Scientific Advice Meeting that was held earlier this month. As a result of the advice, the Company believes that the confirmatory Phase 3 study that was discussed with the U.S. Food & Drug Administration (“FDA”) last March, meets the EMA’s study-design expectations.
Dr. Richard Sachse, Chief Scientific Officer and Chief Medical Officer of the Company stated, “We are very happy with the EMA’s advice as we continue to believe that our trial will confirm the efficacy and safety of this product. In principle, the EMA agreed with our projected protocol design in the evaluation of the product. In addition, it projected that we consider additional aspects regarding the demonstration of reproducibility of a diagnosis made using Macrilen™, which will further enhance the profile of our compound. We believe we will be able to provide the information that EMA requires in a timely and cost‑effective manner.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The company’s product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
Shares of GameStop Corp. (NYSE:GME), during its Tuesday’s current trading session raised 0.70%, and is now trading at $ 43.34.
GameStop Corp., declared they have reached a definitive agreement under which GameStop will acquire all of the outstanding shares of Geeknet’s common stock for $20.00 per share in cash. The transaction has been approved by the board of directors of both companies and will be accomplished by means of a tender offer. The transaction has a total equity value of about $140 million, counting $37 million of cash and cash equivalents as of March 31, 2015.
Geeknet also declared that it had terminated its formerly declared merger agreement with Hot Topic, Inc.. Following discussion with both GameStop and Hot Topic, the Board of Directors of Geeknet determined that the GameStop transaction represented a superior proposal. Geeknet will pay Hot Topic a termination fee following the Hot Topic agreement, for which GameStop has agreed to reimburse Geeknet.
GameStop Corp. operates as a multichannel video game retailer. It sells new and pre-owned video game hardware; physical and digital video game software; pre-owned and value video game products; video game accessories, such as controllers, gaming headsets, memory cards, and other add-ons for use with video game hardware and software; and digital products, counting downloadable content, network points cards, prepaid digital and online timecards, and digitally downloadable software.
Finally, CA, Inc. (NASDAQ:CA), gained 0.54% Tuesday, hitting its highest level.
CA, declared the newest release of its CA Project and Portfolio Administration (CA PPM) solution. CA PPM is the first solution to provide critical administration and business insights from across the enterprise improving planned decision-making for agile businesses operating within the increasingly competitive application economy.
CA PPM is accessible via the cloud or on-premise, and enables companies of all sizes to prioritize planned initiatives and mobilize the right resources. It gives managers fast and easy access to the critical project / initiative information needed to collaborate and make on-the-go portfolio decisions. By facilitating rapid and accurate decision-making, CA PPM assists ensure teams execute on time and achieve aims within budget. CA PPM SaaS is part of the CA Administration Cloud, a portfolio of easy-to-use, easy-to-own solutions that assist organizations manage their technology assets like a business.
CA, Inc. provides information technology (IT) administration software and solutions that assist organizations plan, develop, manage, and secure applications and IT infrastructure in the United States and internationally. The company operates through three segments: Mainframe Solutions, Enterprise Solutions, and Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
